Telesis Bio, Inc. (TBIO) Financials

TBIO Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 105.0 million 58.5 million
2023-06-30 114.5 million 86.6 million
2023-03-31 89.2 million 52.5 million
2022-12-31 81.4 million 34.8 million

TBIO Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -6.0 million 1.2 million
2023-06-30 -11.5 million 1.0 million
2023-03-31 -11.6 million 1.2 million
2022-12-31 -6.4 million 1.2 million

TBIO Net Income

No data available :(

TBIO Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 41.5 million - 29.5 million
2023-06-30 47.5 million 19.9 million 29.4 million
2023-03-31 32.2 million - 22.0 million
2022-12-31 43.8 million - 1.8 million

TBIO Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 29.9 million
2023-06-30 29.8 million
2023-03-31 29.7 million
2022-12-31 29.6 million

TBIO Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 104000 4.1 million 6.3 million 2.7 million
2023-06-30 1.2 million 4.6 million 5.7 million 3.4 million
2023-03-31 470000 5.1 million 5.6 million 3.8 million
2022-12-31 763000 4.1 million 5.5 million 4.7 million

TBIO Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 5.6 million 2.6 million
2023-06-30 8.7 million 3.0 million
2023-03-31 6.3 million 2.8 million
2022-12-31 9.5 million 3.0 million

TBIO

Price: $0.34

52 week price:
0.30
3.01

Earnings Per Share: -1.64 USD

P/E Ratio: -0.25

Exchange: NMS

Sector: Healthcare

Industry: Medical Devices

Volume: 19200

Market Capitalization: 9.9 million

Links: